Showing 311-320 of 360 results for "".
- RealSelf Medical Advisory Board Adds Plastic Surgeon Dr. Arian Mowlavihttps://modernaesthetics.com/news/realself-medical-advisory-board-adds-newport-beach-plastic-surgeon-dr-arian-mowlavi/2472947/Newport Beach, Calif.-based plastic surgeon Arian Mowlavi, MD is now a member of RealSelf’s Medical Advisory Board. “RealSelf is a leader in plastic surgery patient education and I am proud to a member of their Medical Advisory Board,” says Dr. Mowlavi of Cosmetic Plas
- Meet Cynosure’s Upgraded Elite iQ Aesthetic Workstationhttps://modernaesthetics.com/news/meet-cynosures-upgraded-elite-iq-aesthetic-workstation/2472944/Cynosure is launching the Elite iQ platform – the next generation of Cynosure’s Elite+ Aesthetic Workstation and the first Alexandrite-ND: YAG System to U.S., European and Australian mark
- New Officers Announced at American Society for Laser Medicine and Surgeryhttps://modernaesthetics.com/news/new-officers-announced-at-american-society-for-laser-medicine-and-surgery/2472943/Thomas E. Rohrer, MD was introduced as President of the American Society for Laser Medicine and Surgery (ASLMS) during the Board of Directors meeting on April 30, 2020. ASLMS is the world's largest professional organization dedicated to promoting research, education, and high standards of cli
- Revance to Acquire HintMDhttps://modernaesthetics.com/news/revance-to-aquire-hintmd/2472941/Revance Therapeutics, Inc. has acquired HintMD, a financial technology platform for the aesthetics industry. Revance has agreed to pay HintMD’s shareholders a total of 8.54 million shares of Revance common stock, subject to customary adjustments provided in the acquisition agreeme
- Fast Facts on Non-Surgical Cosmetic Procedures in 2019 from the Aesthetic Societyhttps://modernaesthetics.com/news/fast-facts-on-non-surgical-cosmetic-procedures-in-2019-from-the-aesthetic-society-1/2472940/And the Aesthetic Society’s 2019 numbers are in… The top 5 non-surgical procedures performed in 2019 by board-certified U.S. plastic surgeons were: Botulinum Toxin (including Botox, Dysport, Xeomin) 1,712,994 procedures Hyaluronic Acid (includin
- New Aesthetic Society Survey Notes Drop in Breast Augmentation Surgery, Rise in Explantationhttps://modernaesthetics.com/news/new-aesthetic-society-survey-notes-drop-in-breast-augmentation-surgery-rise-in-explantation/2472939/There was a 15 percent decrease in breast augmentation surgery in 2019, according to new statistics from the Aesthetic Society. What’s more, breast implant removal increased by 34.4 percent in 2019. These statistics are likely driven by concerns about breast implant associated-anaplastic la
- TruSculpt Flex from Cutera Scores 2020 Good Housekeeping Awardhttps://modernaesthetics.com/news/trusculpt-flex-from-cutera-scores-2020-good-housekeeping-award/2472925/Congrats! Cutera’s truSculpt flex won a Good Housekeeping 2020 Beauty Award Winner for Ultimate Body Product. truSculpt flex is FDA-cleared for the improvement of abdominal tone, strengthening of the abdominal muscles, and development of a firmer abdomen. It is also cleared for th
- FDA Clears Bimini Health Tech’s Dermapose Access Office-Based Fat Harvesting Systemhttps://modernaesthetics.com/news/fda-clears-bimini-health-techs-dermapose-access-office-based-fat-harvesting-system/2472922/Bimini Health Tech’s received US Food and Drug Administration (FDA) 510(k) clearance for its Dermapose Access, a novel fat harvesting system. Designed for office use, the launch of the Dermapose Access system creates a new pr
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co
- David Long Tapped As Cynosure's Global Chief Financial Officerhttps://modernaesthetics.com/news/david-long-is-cynosures-global-chief-financial-officer/2472908/David Long is Cynosure’s new Chief Financial Officer, effective immediately. Until recently, Long served as CFO at Corindus Vascular Robotics, Inc., where he brought the company public and, ultimately, navigated its